Catalyst Wire Dossier Catalyst Wire Dossier

ORKAMBI

lumacaftor and ivacaftor · Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

37 regulatory and trial events tracked for ORKAMBI, covering 2013-11-15 to 2026-07-22. Get the full timeline:

Most recent: EMA Authorised: Orkambi (Lumacaftor;ivacaftor) — Vertex Pharmaceuticals (Ireland) Limited

See pricing